Compare VanEck Junior Gold Miners (GDXJ) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Junior Gold Miners vs 22nd Century Group Inc — how do they compare? VanEck Junior Gold Miners trades at $93.3, while 22nd Century Group Inc trades at $4.27 (market cap $1.52M). Which is the better fit depends on your goals.
| GDXJ | XXII | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Technology |
52-Week High | $156.19 | $1.47K |
52-Week Low | $64.22 | $3.90 |
Market Cap | — | $1.52M |
Enterprise Value | — | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GDXJ, the VanEck Junior Gold Miners ETF, trades at $93.33, down 5.12% in the last 24 hours amid a bearish technical signal. Technical indicators show moving averages are bearish, while oscillators are neutral. Recent news highlights underperformance versus peers and questions about its small-cap focus. Key support lies at $91, with resistance at $98.
The outlook for GDXJ is cautious due to weak technicals and negative sentiment. Risks include Federal Reserve rate hike expectations and competition from other gold ETFs. Analyst consensus is bearish, with limited fundamental data available. Investors should weigh macroeconomic factors affecting gold miners before considering a position.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
